Caracterización de pacientes con dermatomiositis en un hospital universitario en Colombia

Mainetti, 2017, Cutaneous manifestations of dermatomyositis: A comprehensive review, Clin Rev Allergy Immunol, 53, 337, 10.1007/s12016-017-8652-1 Restrepo, 2010, Manifestaciones cutáneas de la dermatomiositis, Rev Asoc Colomb Dermatol, 18, 18 Schmidt, 2018, Current classification and management of inflammatory myopathies, J Neuromuscul Dis, 5, 109, 10.3233/JND-180308 Dourmishev, 2017, Inflammatory myopathies with cutaneous involvement: From diagnosis to therapy, Folia Med (Plovdiv), 59, 7, 10.1515/folmed-2017-0003 Yang, 2018, Advances in biomarkers for dermatomyositis, Clin Chim Acta, 482, 172, 10.1016/j.cca.2018.03.042 DeWane, 2020, Dermatomyositis: Clinical features and pathogenesis, J Am Acad Dermatol, 82, 267, 10.1016/j.jaad.2019.06.1309 Sasaki, 2018, Current diagnosis and treatment of polymyositis and dermatomyositis, Mod Rheumatol, 28, 913, 10.1080/14397595.2018.1467257 Isak, 2018, Recent developments on treatment strategies and the prognosis of dermatomyositis: A review, J Dermatolog Treat, 29, 450, 10.1080/09546634.2017.1403549 Neri, 2014, Clinically amyopathic dermatomyositis: Analysis of a monocentric cohort, J Clin Neuromuscul Dis, 15, 157, 10.1097/CND.0000000000000038 de Souza, 2012, Adult dermatomyositis: Experience of a Brazilian tertiary care center, Rev Bras Reumatol, 52, 897 Lopez, 2009, Dermatomyositis: Cutaneous features, clinical course, and association with malignancies in 73 patients in a Hispanic population, J Am Acad Dermatol, 2515 Fardet, 2009, Factors associated with underlying malignancy in a retrospective cohort of 121 Patients with dermatomyositis, Medicine (Baltimore), 88, 91, 10.1097/MD.0b013e31819da352 Hiketa, 1992, Juvenile dermatomyositis: A statistical study of 114 patients with dermatomyositis, J Dermatol, 19, 470, 10.1111/j.1346-8138.1992.tb03264.x Teh, 2012, Polymyositis and dermatomyositis in Sarawak: A profile of patients treated in the Sarawak general hospital, Rheumatol Int, 32, 265, 10.1007/s00296-010-1745-2 Koh, 1993, Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients, Ann Rheum Dis, 52, 857, 10.1136/ard.52.12.857 Sun, 2015, Juvenile dermatomyositis: A 20-year retrospective analysis of treatment and clinical outcomes, Pediatr Neonatol, 56, 31, 10.1016/j.pedneo.2014.02.006 Vega Castro K, Rondón Herrera F. Descripción de los anticuerpos, y manifestaciones clínicas de pacientes con polimiositis y dermatomiositis. Bogotá: Universidad Nacional de Colombia Sede Bogotá, Facultad de Medicina, Departamento de Medicina Interna. 2014. Sato, 2009, A Brazilian registry of juvenile dermatomyositis: Onset features and classification of 189 cases, Clin Exp Rheumatol, 27, 1031 Caggiani, 2018, Dermatomiositis juvenil: experiencia de 13 años en un hospital de atención terciaria. Análisis de 17 casos clínicos, Arch Pediatr Urug, 89, 99 Hoesly, 2019, Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis, J Am Acad Dermatol, 80, 1364, 10.1016/j.jaad.2018.11.023 Marie, 2011, Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients, Arthritis Rheum, 63, 3439, 10.1002/art.30513 Scola, 2000, Diagnosis of dermatomyositis and polymyositis: A study of 102 cases, Arq Neuropsiquiatr, 58, 789, 10.1590/S0004-282X2000000500001 Chen, 2019, Clinical analysis for 108 cases of dermatomyositis, J Cent South Univ (Medical Sci, 44, 1157 Sallum, 2002, Juvenile dermatomyositis: Clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients, Arq Neuropsiquiatr, 60, 889, 10.1590/S0004-282X2002000600001 Mandel, 2017, Idiopathic inflammatory myopathies: A review of the classification and impact of pathogenesis, Int J Mol Sci, 18, 10.3390/ijms18051084 Sigurgeirsson, 1992, Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study, N Engl J Med, 326, 363, 10.1056/NEJM199202063260602 Wu, 2018, Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study, PLoS One, 13, 1 Murray, 2015, A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis, Arthritis Care Res (Hoboken), 67, 673, 10.1002/acr.22501